Evaluation of administration-related reactions with subcutaneous daratumumab with and without premedication.

MLA

Padmaraju, Kashyap, et al. “Evaluation of Administration-Related Reactions with Subcutaneous Daratumumab with and without Premedication.” The Oncologist, vol. 29, no. 9, Sept. 2024, pp. 806–10. EBSCOhost, https://doi.org/10.1093/oncolo/oyae158.

APA

Padmaraju, K., Kelly, K., Jakubowiak, A. J., & Derman, B. A. (2024). Evaluation of administration-related reactions with subcutaneous daratumumab with and without premedication. The Oncologist, 29(9), 806–810. https://doi.org/10.1093/oncolo/oyae158

Chicago

Padmaraju, Kashyap, Kaitlin Kelly, Andrzej J Jakubowiak, and Benjamin A Derman. 2024. “Evaluation of Administration-Related Reactions with Subcutaneous Daratumumab with and without Premedication.” The Oncologist 29 (9): 806–10. doi:10.1093/oncolo/oyae158.